Systemic Inertia in Addiction Care: Institutional Hesitancy and Ethical Barriers to Buprenorphine Initiation

This editorial examines a case illustrating the ethical tensions that arise when systemic uncertainty and institutional anxiety delay evidence-based treatment for opioid use disorder (OUD). A patient admitted through an emergency department received buprenorphine only after a delay between order and administration, reflecting the institution's limited readiness for medication for OUD (MOUD) implementation. Although protocols existed, they were inconsistently applied. The commentary explores how surveillance-oriented systems, stigma, and fear of regulatory scrutiny transform care into cautious oversight. It argues that moral readiness for MOUD requires institutional trust, interprofessional collaboration, and procedural clarity to ensure that fear of error never outweighs the ethical imperative to relieve suffering and save lives.